Recent studies funded by the National Institute of Arthritis, Musculoskeletal and Skin Diseases and a Veterans Affairs Merit Award report that ultraviolet light from the sun initiates an enzyme that aids skin cancer cells to grow and thrive. The report also reveals a second way cancer hijacks regular body processes commented Dr. Wendy Bollag, who [...]

A clinical trial published online in The Journal of the National Cancer Institute reported that a nonsteroidal anti-inflammatory drug (NSAID) called Celecoxib may help prevent nonmelanoma skin cancers in patients with actinic keratosis. Celecoxib works by inhibiting the enzyme cyclooxygenase 2, which has been linked to UV-induced nonmelanoma skin cancers. With nonmelanoma cancers being so [...]

Researchers working on the development of new therapies to be used in the treatment of skin and lung cancer recently announced the development of a new therapy that involves the use of a suicide coliphage-gene (gene E), which is able to induce death to cells that are transfected with it. The efficacy of this newly [...]

The US Food & Drug Administration (FDA) recently fast tracked the approval process of a promising treatment for Metastatic Melanoma following the publication of the results of a study conducted at the John Theurer Cancer Center at the Hackensack University Medical Center in New Jersey. The FDA accepted an application for the approval of Ipilimumab [...]

A new breakthrough in the treatment of advanced melanoma skin cancer was announced in a recent issue of the New England Journal of Medicine, with the new experimental treatment said to have been successful in reducing the size of a skin cancer tumor by up to 80 percent. The new treatment is currently known as [...]